BALYASNY ASSET MANAGEMENT L.P. - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 273 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$8,199,004
+112.8%
81,299
+119.1%
0.02%
+70.0%
Q1 2023$3,853,102
-25.7%
37,099
-36.5%
0.01%
-28.6%
Q4 2022$5,182,692
-75.0%
58,469
-73.0%
0.01%
-79.1%
Q2 2022$20,732,000
-32.6%
216,495
+4.5%
0.07%
-30.9%
Q1 2022$30,770,000
+112.7%
207,136
+87.3%
0.10%
+61.7%
Q3 2021$14,466,000
-10.1%
110,571
-10.3%
0.06%
-24.1%
Q1 2021$16,093,000
+48.1%
123,231
-10.8%
0.08%
-1.2%
Q3 2020$10,864,000
-25.8%
138,097
-32.1%
0.08%
-37.0%
Q2 2020$14,643,000
+199.3%
203,403
+255.7%
0.13%
+309.7%
Q2 2019$4,893,000
+401.8%
57,182
+388.0%
0.03%
+416.7%
Q1 2019$975,000
+157.3%
11,718
+98.5%
0.01%
+100.0%
Q4 2018$379,000
+23.9%
5,904
+52.6%
0.00%
+200.0%
Q3 2018$306,000
-62.5%
3,868
-65.4%
0.00%
-75.0%
Q2 2018$817,000
-2.6%
11,164
-15.7%
0.00%0.0%
Q1 2018$839,000
-87.2%
13,251
-89.7%
0.00%
-85.2%
Q2 2017$6,562,000
-49.6%
128,809
-56.1%
0.03%
-55.7%
Q1 2017$13,030,000
+66.8%
293,407
+50.5%
0.06%
+35.6%
Q3 2016$7,812,000
+3806.0%
195,001
+4545.1%
0.04%
+4400.0%
Q2 2016$200,000
-89.5%
4,198
-91.9%
0.00%
-93.3%
Q3 2014$1,899,000
-37.1%
51,553
-25.8%
0.02%
-55.9%
Q1 2014$3,017,000
+447.5%
69,433
+435.6%
0.03%
+385.7%
Q4 2013$551,00012,9630.01%
Other shareholders
CONMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders